Related Experiment Video
Updated: Apr 25, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents
Hanns Möhler1, Rolf W Pfirrmann2, Karl Frei3
1Institute of Pharmacology, University of Zurich and Department of Chemistry and Applied Biosciences, ETH Zurich, 8057 Zurich, Switzerland.
Abstract:
Targeting the oxygen stress response pathway is considered a promising strategy to exert antineoplastic activity in a broad spectrum of tumor types. Supporting this view, we summarize the mechanism of action of Taurolidine and Piperlongumine, two antineoplastic agents with strikingly broad tumor selectivity. Taurolidine enhances the oxidative stress (ROS) selectively in tumor cells. Its cytotoxicity for various tumor cells in vitro and in vivo, which includes tumor stem cells, is based on the induction of programmed cell death, largely via apoptosis but also necroptosis and autophagy. The redox-directed mechanism of action of Taurolidine is apparent from the finding that reducing agents e.g., N-acetylcysteine or glutathione impair its cytotoxicity, while its effectiveness is enhanced by agents which inhibit the cellular anti‑oxidant capacity. A similar redox-directed antineoplastic action is shown by Piperlongumine, a recently described experimental drug of plant origin. Taurolidine is particularly advantageous in surgical oncology as this taurine-derivative can be applied perioperatively or systemically with good tolerability as shown in initial clinical applications.
Insights
Two antineoplastic agents, Taurolidine and Piperlongumine, target tumor cell oxidative stress for broad-spectrum cancer treatment. Their efficacy relies on inducing programmed cell death, with Taurolidine showing promise in surgical oncology.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Targeting the oxygen stress response pathway is a promising strategy for broad-spectrum antineoplastic activity.
- Taurolidine and Piperlongumine are antineoplastic agents with broad tumor selectivity.
- Understanding their redox-directed mechanisms is crucial for developing novel cancer therapies.
Purpose of the Study:
- To summarize the mechanism of action of Taurolidine and Piperlongumine.
- To highlight their selective enhancement of oxidative stress in tumor cells.
- To discuss the potential of Taurolidine in surgical oncology.
Main Methods:
- Review of existing literature on Taurolidine and Piperlongumine.
- Analysis of their effects on oxidative stress (ROS) in tumor cells.
- Evaluation of their induction of programmed cell death (apoptosis, necroptosis, autophagy).
Main Results:
- Taurolidine selectively enhances oxidative stress in tumor cells, leading to cytotoxicity.
- Its efficacy is modulated by reducing agents and agents inhibiting antioxidant capacity.
- Piperlongumine exhibits a similar redox-directed antineoplastic action.
- Taurolidine demonstrated efficacy against tumor stem cells in vitro and in vivo.
- Initial clinical applications show good tolerability of Taurolidine.
Conclusions:
- Taurolidine and Piperlongumine represent promising redox-directed antineoplastic agents.
- Taurolidine's ability to induce programmed cell death and its favorable tolerability make it advantageous in surgical oncology.
- Further research into these agents could lead to novel cancer treatment strategies.
Related Concept Videos
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules

